David J Rickles

Title: David J Rickles: Innovator in Antibody Research

Introduction

David J Rickles is a prominent inventor based in Manhattan Beach, CA (US). He has made significant contributions to the field of antibody research, particularly in the development of monoclonal antibodies that target melanin and centrin-1. With a total of 2 patents, Rickles has established himself as a key figure in therapeutic innovations.

Latest Patents

Rickles' latest patents include "Melanin antibodies and uses thereof," which provides monoclonal antibodies that specifically bind to melanin. These antibodies may be chimeric or humanized and have potential therapeutic applications for treating or preventing melanoma. Another notable patent is "Antibodies to centrin-1, methods of making, and uses thereof," which details antibodies that specifically bind to centrin-1. This invention includes methods for using these antibodies in the treatment, prevention, detection, imaging, and diagnosis of various cancers, including pancreatic and prostate cancer.

Career Highlights

Throughout his career, David J Rickles has worked with several esteemed organizations, including Radimmune Therapeutics, Inc. and the Albert Einstein College of Medicine. His work has focused on advancing the understanding and application of antibodies in cancer treatment.

Collaborations

Rickles has collaborated with notable colleagues such as Ekaterina Dadachova and Ruth A Bryan, contributing to the advancement of research in antibody therapies.

Conclusion

David J Rickles is a distinguished inventor whose work in antibody research has the potential to impact cancer treatment significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.